Transcriptomic and proteomic analyses of Upc2A under Candida glabrata hypoxic growth
Transcriptomic and proteomic analyses of Upc2A under Candida glabrata hypoxic growth
批准号:
10976654
负责人:
Bao Gia Vu
金额:
$10.1万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-02-01 至 2025-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Adaptation to hypoxia is crucial for human pathogens like Candida glabrata, since the condition
mimics the infection environment inside the host. Hence, our long-term goal is to identify
essential factors that are required for C. glabrata hypoxic growth, and to exploit them for novel
Candida drug development. However, the transcriptional responses of C. glabrata shifting from
normoxic respiratory to hypoxic metabolism is unexplored. My recent work has indicated that
the transcription factor Upc2A is activated hypoxically, and its function is essential for C.
glabrata hypoxic growth. Although Upc2A roles in C. glabrata drug resistance mechanism is well
characterized, its intrinsic function in C. glabrata biology remains under-studied. This application
takes an interdisciplinary approach combining cutting-edge next generation sequencing,
proteomics, and molecular genetic techniques to determine the fundamental function of Upc2A
in C. glabrata hypoxic physiology. Our overall objectives are (i) to decode the comprehensive
interaction networks of Upc2A target genes as well as genes that are required for C. glabrata
hypoxic adaptation, and (ii) to identify Upc2A-associated proteins required for the activity of this
transcription factor and the organism’s hypoxic growth. This knowledge will provide more
understanding about C. glabrata physiology under hypoxic growth conditions which could
ultimately be translated into the pathogenesis of this organism inside the host.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
-
批准号:10643423
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2023
-
负责人:Bao Gia Vu
-
依托单位:
海外基金